S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   430.55 (-0.12%)
AAPL   169.14 (-2.06%)
MSFT   416.88 (+0.78%)
META   501.90 (+0.33%)
GOOGL   154.95 (+0.06%)
AMZN   183.94 (+0.17%)
TSLA   156.66 (-2.98%)
NVDA   875.51 (+1.80%)
AMD   163.68 (+2.10%)
NIO   3.83 (-1.54%)
BABA   70.04 (-0.82%)
T   16.03 (-1.29%)
F   12.17 (-0.49%)
MU   121.28 (-0.07%)
GE   156.07 (+1.54%)
CGC   6.81 (-2.44%)
DIS   114.05 (+0.97%)
AMC   2.82 (+14.17%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.48 (-1.00%)
OTCMKTS:SARTF

Sartorius Aktiengesellschaft (SARTF) Stock Price, News & Analysis

$290.00
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$290.00
$290.00
50-Day Range
$286.27
$309.04
52-Week Range
$198.00
$364.00
Volume
N/A
Average Volume
6 shs
Market Capitalization
N/A
P/E Ratio
89.51
Dividend Yield
N/A
Price Target
N/A
SARTF stock logo

About Sartorius Aktiengesellschaft Stock (OTCMKTS:SARTF)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

SARTF Stock Price History

SARTF Stock News Headlines

Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
Sartorius Stedim Biotech SA DIM
Sartorius AG ADR (Representing Preference Share)
Aktuelle Empfehlungen zur SARTORIUS STEDIM BIOTECH Aktie
Sartorius AG DRC (SRT4y)
Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
Sartorius Aktiengesellschaft (SRT.DE)
Sartorius To Join The DAX Blue Chip Index
Sartorius acquires cell culture specialist Xell AG
See More Headlines
Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2024
Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
14,614
Year Founded
1870

Profitability

Net Income
$221.98 million
Pretax Margin
11.36%

Debt

Sales & Book Value

Annual Sales
$3.67 billion
Cash Flow
$29.00 per share
Book Value
$81.84 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.93

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Joachim Kreuzburg (Age 59)
    Chairman of Executive Board, CEO & Interim CFO
    Comp: $1.16M
  • Dr. Rene Faber (Age 49)
    Head of Bioprocess Solutions Division & Member of Executive Board
    Comp: $663.99k
  • Dr. Alexandra Gatzemeyer
    Head of the Lab Products & Services Division and Member of Executive Board
  • Ms. Petra Kirchhoff (Age 55)
    Head of Corporate Communications & Investor Relations and Member of Supervisory Board
    Comp: $88.82k
  • Ms. Patricia Spannagel
    Head of Quality Assurance - Mechatronics Division Goettingen
  • Ralf Mohrschladt
    Physicist & Head of Supply Chain Management - Germany
  • Ms. Petra Muller
    Head of Investor Relations
  • Mr. Maurice Phelan
    President of Sartorius North America
  • Dr. Theo Thijssen
    President of Environmental Technology Division

SARTF Stock Analysis - Frequently Asked Questions

Should I buy or sell Sartorius Aktiengesellschaft stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SARTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SARTF, but not buy additional shares or sell existing shares.
View SARTF analyst ratings
or view top-rated stocks.

How have SARTF shares performed in 2024?

Sartorius Aktiengesellschaft's stock was trading at $285.04 on January 1st, 2024. Since then, SARTF stock has increased by 1.7% and is now trading at $290.00.
View the best growth stocks for 2024 here
.

How were Sartorius Aktiengesellschaft's earnings last quarter?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) released its earnings results on Friday, February, 16th. The company reported $1.01 EPS for the quarter, missing analysts' consensus estimates of $1.31 by $0.30. The firm had revenue of $915.06 million for the quarter, compared to the consensus estimate of $900 million. Sartorius Aktiengesellschaft had a trailing twelve-month return on equity of 12.44% and a net margin of 6.04%.

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Sartorius Aktiengesellschaft have any subsidiaries?
The following companies are subsidiares of Sartorius Aktiengesellschaft: ALS Automated Lab Solutions GmbH, BI Shanghai Co. Ltd., BIA Separations, Beit Haemek Import and Marketing Agricultural Cooperative Society Ltd., Biological Industries, Biological Industries Hong Kong Ltd., Biological Industries Israel Beit Haemek Ltd., Biological Industries USA Inc., CellGenix Inc., Cellca GmbH, Denver Instrument (Beijing) Co. Ltd., Essen BioScience, Essen BioScience K.K., Essen BioScience Ltd., Essen Instruments Inc., IntelliCyt Corporation, LLC Sartogosm, LLC Sartorius RUS, LLC Sartorius Stedim RUS, LabTwin GmbH, Life Science Factory Management GmbH, Life Science Factory gGmbH, MKS Instruments AB (Umetrics), Novasep’s chromatography division, SI Grone 1-Verwaltungs-GmbH, SI Weende-Verwaltungs-GmbH, SIV Grone 1 GmbH & Co. KG, SIV Grone 2 GmbH, SIV Weende GmbH & Co. KG, SWT Treuhand GmbH, Sartonets Taiwan Inc, Sartonets Taiwan Inc., Sartorius (Shanghai) Trading Co. Ltd., Sartorius AG, Sartorius Argentina S.A., Sartorius Australia Pty. Ltd., Sartorius Austria GmbH, Sartorius Belgium N.V., Sartorius Biohit Liquid Handling Oy, Sartorius Canada Inc., Sartorius Corporate Administration GmbH, Sartorius Corporation, Sartorius France S.A.S., Sartorius Hong Kong Ltd., Sartorius Hungária Kft., Sartorius India Pvt. Ltd., Sartorius Ireland Ltd., Sartorius Israel Ltd., Sartorius Italy S.r.l., Sartorius Japan K.K., Sartorius Korea Biotech Co. Ltd., Sartorius Korea Ltd., Sartorius Lab Holding GmbH, Sartorius Lab Instruments GmbH & Co. KG, Sartorius Malaysia Sdn. Bhd., Sartorius Netherlands B.V., Sartorius Nordic Oy, Sartorius North America Inc., Sartorius Peru S.A.C., Sartorius Poland Sp. z o.o., Sartorius Scientific Instruments (Beijing) Co. Ltd., Sartorius Singapore Pte. Ltd., Sartorius South Africa (Pty) Ltd., Sartorius Spain S.A., Sartorius Stedim (Shanghai) Trading Co. Ltd., Sartorius Stedim Aseptics S.A.S., Sartorius Stedim Australia Pty. Ltd., Sartorius Stedim Austria GmbH, Sartorius Stedim Belgium N.V., Sartorius Stedim BioOutsource Ltd., Sartorius Stedim Bioprocess S.A.R.L., Sartorius Stedim Biotech (Beijing) Co. Ltd., Sartorius Stedim Biotech GmbH, Sartorius Stedim Biotech S.A., Sartorius Stedim Cellca GmbH, Sartorius Stedim Data Analytics AB, Sartorius Stedim FMT S.A.S., Sartorius Stedim Filters Inc., Sartorius Stedim France S.A.S., Sartorius Stedim Hungária Kft., Sartorius Stedim India Pvt. Ltd., Sartorius Stedim Ireland Ltd., Sartorius Stedim Italy S.p.A., Sartorius Stedim Japan K.K., Sartorius Stedim Lab Ltd., Sartorius Stedim Malaysia Sdn. Bhd., Sartorius Stedim Netherlands B.V., Sartorius Stedim Nordic Oy, Sartorius Stedim North America Holding GmbH, Sartorius Stedim North America Inc., Sartorius Stedim Plastics GmbH, Sartorius Stedim Poland Sp. z o.o., Sartorius Stedim Singapore Pte. Ltd., Sartorius Stedim Spain S.A., Sartorius Stedim Switzerland AG, Sartorius Stedim Systems GmbH, Sartorius Stedim UK Ltd., Sartorius UK Ltd., Sartorius Ventures GmbH, Sartorius Vietnam Co. Ltd., Sartorius Weighing Technology GmbH, Sartorius de México S.A. de C.V., Sartorius do Brasil Ltda., TAP Biosystems (PHC) Ltd., TAP Biosystems Group Ltd., TAP Biosystems Ltd., TAP ESOP Management Ltd., The Automation Partnership Cambridge Ltd., ViroCyt Inc, WaterSep BioSeparations LLC, Xell AG, and kSep Holdings Inc..
Read More
This page (OTCMKTS:SARTF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners